Prostate Cancer Survival Rate- Thanks to early detection and modern intervention, now survival rates for prostate cancer have greatly improved from the last three decades.
In reality, not everyone would be willing to know the cancer's survival rate. The term survival rate is used by doctors to explain a person's current health status and discuss the outcome based on his present state.
Prostate cancer is less serious and is the second leading type of cancer in men after skin cancer. Prostate Cancer survival rate depends on the type of prostate cancer that could affect a man. There are those that are more progressive and can readily spread without even diagnosed, while others are slowly developed.
In men, prostate cancer is regarded as less severe when compared to their other diseases. With early diagnosis and its slow-progressing nature, prostate cancer is now one of the cancers with the highest survival rates.
Prostate Cancer survival rate is higher compared to other health problems. 1 in every 36 men dies due the cancer. This type of cancer affects men as they get old and mostly, is less debilitating and non-aggressive.
With high incidence of Prostate Cancer survival rate, more men die due to diabetes, heart attack, stroke, rather than because of the cancer.
What does Prostate Cancer survival rate really means? A 5-year survival rate means in at least five years, it refers to the percentage of people who have prostate cancer and can still live for five years after cancer was detected.
According to the most relevant data gathered by the American Cancer Society, the Prostate Cancer survival rate for all stages of prostate cancer is:
The relative 5-year survival rate is roughly 100 percent.
The relative 10-year survival rate is 99 percent.
The relative 15-year survival rate is 94 percent.
The data explains that a 5-year prostrate cancer survival rate is based on men who were detected and were treated over five years earlier, 10-year survival rate refers to the patients detected over 10 years ago and 15-year survival rate is focused on patients who were diagnosed with the tumor for at least 15 years earlier.
